NASDAQ · CBUSMaterialsAgricultural Chemicals

Cibus financials

$1.62+0.62%
Close Oct 1, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
Revenue$3.6M$4.3M$1.8M
Gross profit$3.6M$4.3M$1.8M
Gross margin100.0%100.0%100.0%
Operating income-$97.5M-$258.4M-$318.9M
Net income-$127.1M-$251.4M-$267.6M
Net margin−3492.3%−5898.4%−14729.1%
Diluted EPS$-2.78$-10.83$-25.95
EBITDA-$61.5M-$70.1M-$64.8M
Operating cash flow-$50.6M-$58.0M-$46.2M
Free cash flow-$51.2M-$58.9M-$50.5M
Diluted shares45.8M23.2M10.3M

Balance sheet

Period endDec 31Dec 31Dec 31
Cash & equivalents$9.9M$14.4M$32.7M
Short-term investments$0.00$0.00$0.00
Total debt$528.0K$775.0K$1.7M
Total assets$305.0M$350.1M$544.4M
Total liabilities$283.2M$252.2M$206.1M
Shareholders' equity$21.8M$92.2M$293.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology